The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index; 1 of the 19 sources its claims cite were checked for support.
Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.
Open accessAbstract
To determine the plasma epinephrine thresholds for its metabolic and hemodynamic actions and plasma epinephrine metabolic clearance rates, 60-min intravenous epinephrine infusions at nominal rates of 0.1, 0.5, 1.0, 2.5, and 5.0 microgram/min were performed in each of six normal human subjects. These 30 infusions resulted in steady-state plasma epinephrine concentrations ranging from 24 to 1,020 pg/ml. Plasma epinephrine thresholds were 50-100 pg/ml for increments in heart rate, 75-125 pg/ml for increments in blood glycerol and systolic blood pressure, 150-200 pg/ml for increments in plasma glucose (the resultant of increments in glucose production and decrements in glucose clearance), blood lactate, blood beta-hydroxybutyrate, and diastolic blood pressure, and greater than 400 pg/ml for early decrements in plasma insulin. Changes in blood alanine, plasma glucagon, plasma growth hormone, and plasma cortisol were not detected. At steady-state plasma epinephrine concentrations of 24-74 pg/ml, values overlapping the basal normal range, the mean (+/-SE) plasma metabolic clearance rate of epinephrine was 52 +/- 4 ml x min-1 x kg-1; this value rose to 89 +/- 6 ml x min-1 x kg-1 (P less than 0.01) at steady-state epinephrine concentrations of 90-1,020 pg/ml. We conclude that in human subjects: (a) the plasma epinephrine thresholds for its hemodynamic and metabolic actions lie within the physiologic range, (b) epinephrine and norepinephrine accelerate their own metabolic clearance, and (c) epinephrine is 10 times more potent than norepinephrine.
Overview
CoChat Summary
TL;DR
In six normal human subjects, graded epinephrine infusions showed that hemodynamic and metabolic thresholds occur within the physiologic plasma epinephrine range. The study also found that epinephrine accelerates its own metabolic clearance and is about 10 times more potent than norepinephrine.
Key findings
- Across 30 infusions, steady-state plasma epinephrine concentrations ranged from 24 to 1,020 pg/ml. Thresholds were 50–100 pg/ml for heart-rate increments; 75–125 pg/ml for systolic blood pressure and blood glycerol increments; 150–200 pg/ml for plasma glucose, glucose production, glucose clearance, blood lactate, blood β-hydroxybutyrate, and diastolic blood pressure changes; and >400 pg/ml for early plasma insulin decrements. No significant changes were detected in blood alanine, plasma glucagon, growth hormone, or cortisol.
- Plasma epinephrine metabolic clearance rate was 52±4 ml·min⁻¹·kg⁻¹ at steady-state epinephrine concentrations of 24–74 pg/ml, overlapping the basal normal range, and rose to 89±6 ml·min⁻¹·kg⁻¹ at 90–1,020 pg/ml (P < 0.01), an approximately 70% increase.
- From earlier norepinephrine data, plasma norepinephrine metabolic clearance rate was 25±4 ml·min⁻¹·kg⁻¹ at 229–345 pg/ml and 39±3 ml·min⁻¹·kg⁻¹ at higher levels (P < 0.02), suggesting catecholamines accelerate their own clearance.
- Epinephrine thresholds for direct metabolic and hemodynamic effects (<200 pg/ml) were about 10% of previously determined norepinephrine thresholds (1,500–2,000 pg/ml), indicating epinephrine is ~10-fold more potent.
Methods
- Six normal subjects (five men, one woman) each received five 60-min intravenous epinephrine infusions at nominal rates of 0.1, 0.5, 1.0, 2.5, and 5.0 μg/min after an overnight fast, supine, with infusions separated by at least 1 wk.
- Plasma epinephrine and norepinephrine were measured by a single isotope derivative method; glucose by glucose oxidase; insulin, glucagon, and growth hormone by radioimmunoassay; cortisol by competitive protein binding; lactate, alanine, β-hydroxybutyrate, and glycerol by microfluorometric enzymatic techniques. Glucose kinetics used a primed continuous infusion of [6,6-²H₂]glucose with Steele’s equations for nonsteady-state conditions.
- Plasma epinephrine metabolic clearance rate was calculated as measured infusion rate divided by the difference between steady-state and basal plasma epinephrine. Thresholds were estimated by inspection of semilogarithmic plots, extending regression lines through changed data points to the line of no change, and tended to be confirmed by nonlinear least squares regression.
Limitations
- The paper states that the metabolic clearance calculation assumes basal endogenous epinephrine release continues during infusion; if endogenous release ceases, the calculation overestimates clearance, especially at lower steady-state concentrations. It also states that extremity epinephrine uptake may cause overestimation of epinephrine clearance and underestimation of norepinephrine clearance.
- The paper states that threshold estimates were obtained by inspection and extrapolation of the central linear portion of sigmoidal dose-response curves, providing a maximum estimate; nonlinear least squares regression tended to confirm these values.
- Evident from the text: the sample was small (six normal subjects, five men and one woman), and the study examined only normal human subjects, so findings may not generalize to women, other populations, or pathophysiologic states. The authors also note one discrepancy with earlier studies: they did not observe an increase in plasma glucagon during epinephrine infusions.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 0 Not valid · 10 Not checked · 36 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As noted earlier, plasma epinephrine concentrations of this magnitude do occur during heavy exercise and absolute hypoglycemia, as well as during a variety of acute illnesses.”
What the sources say
- Not checked — no full text of the sourcecites [27] Galbo, H., J. J. Holst, and N. J. Christensen. 1975. Glucagon and plasma catecholamine responses to graded and prolonged exercise in man. J. Appl. Physiol. 38: 70–76. source
- Partly supportedcites [28] Garber, A. J., P. E. Cryer, J. V. Santiago, M. W. Haymond, A. S. Pagliara, and D. M. Kipnis. 1976. The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J. Clin. Invest. 58: 7-15. sourceExperimental — accuracy not yet measured
Our copy supports only the hypoglycemia limb of the claim: RESULTS p. 4 reports mean plasma epinephrine rising from 43±2 pg/ml to maximal levels of 2,200±660 pg/ml (50× basal) during insulin-induced hypoglycemia (plasma glucose 89±3 → 39±2 mg/dl, INTRODUCTION p. 1), i.e. concentrations far above 400 pg/ml in absolute hypoglycemia. The exercise and acute-illness limbs are not in our copy — METHODS p. 2 states subjects were maintained on absolute bed rest, and no passage reports epinephrine during heavy exercise or during acute illness; the DISCUSSION (p. 6) instead closes by saying a role for adrenergic mechanisms in 'more physiologic fluctuations' of plasma glucose 'remains to be established.' Searched: exercise/physical exertion, acute illness/stress, epinephrine >400 pg/ml. (LLM, conf=0.75)
- Not matchedcites [30]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“glucose clearance declined and remained suppressed during the infusion of epinephrine at the higher infusion rates”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“glucose utilization did not change”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“but lower for increments in blood glycerol, 75–125 pg/ml”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
In the paper
“As noted previously (25), glucose production rose transiently, returning to near base line by 60 min”
What the sources say
- Not checked — no full text of the sourcecites [25] Rizza, R. A., M. W. Haymond, P. E. Cryer, and J. E. Gerich. 1979. Differential effects of physiologic concentrations of epinephrine on glucose production and disposal in man. Am. J. Physiol. 237: E356–E362. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
32 more claims
Create a free account to see all 47 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 7
- It may state two separate claims as one. 5
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“plasma epinephrine concentrations do not commonly achieve the threshold level required to affect basal glucose metabolism (7).”
From Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion (1983) · cites this paper as [7]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“a more than eightfold increase in mean plasma epinephrine to a level known to have hyperglycemic effects in man (38).”
From Epinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man (1984) · cites this paper as [38]
Citations
Cites
Effect of Ischemia on Known Substrates and Cofactors of the Glycolytic Pathway in Brain
Lowry, O. H., Passonneau, J. V., Hasselberger, F. X., & Schulz, D. W. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51740-3 · Cited by 2,221
Cryer, P. E., Haymond, M. W., Santiago, J. V., & Shah, S. D. (1976) · New England Journal of Medicine · doi:10.1056/nejm197609092951101 · Cited by 1,101
Self-citationHormone-fuel interrelationships during fasting.
Cahill, G. F., Herrera, M. G., Morgan, A. P., Soeldner, J. S., Steinke, J., Levy, P. L., Reichard, G. A., & Kipnis, D. M. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105481 · Cited by 1,036
A simplified radiometric assay for plasma norepinephrine and epinephrine
Passon, P. G., & Peuler, J. D. (1973) · Analytical Biochemistry · doi:10.1016/0003-2697(73)90517-4 · Cited by 637
A Sensitive Double Antibody Immunoassay for Human Growth Hormone in Plasma
SCHALCH, D. S., & PARKER, M. L. (1964) · Nature · doi:10.1038/2031141a0 · Cited by 635
Measurement of “true” glucose production rates in infancy and childhood with 6,6-dideuteroglucose
Bier, D. M., Leake, R. D., Haymond, M. W., Arnold, K. J., Gruenke, L. D., Sperling, M. A., & Kipnis, D. M. (1977) · Diabetes · doi:10.2337/diab.26.11.1016 · Cited by 444
Self-citationGlucagon and plasma catecholamine responses to graded and prolonged exercise in man
Galbo, H., Holst, J. J., & Christensen, N. J. (1975) · Journal of Applied Physiology · doi:10.1152/jappl.1975.38.1.70 · Cited by 406
Immunoassay of Insulin Using a Two-Antibody System.
Morgan, C. R., & Lazarow, A. (1962) · Experimental Biology and Medicine · doi:10.3181/00379727-110-27411 · Cited by 367
Garber, A. J., Cryer, P. E., Santiago, J. V., Haymond, M. W., Pagliara, A. S., & Kipnis, D. M. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108460 · Cited by 351
Self-citationDetermination of norepinephrine apparent release rate and clearance in humans
Esler, M., Jackman, G., Bobik, A., Kelleher, D., Jennings, G., Leonard, P., Skews, H., & Korner, P. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90371-0 · Cited by 344
Cited by
Romijn, J. A., Coyle, E. F., Sidossis, L. S., Gastaldelli, A., Horowitz, J. F., Endert, E., & Wolfe, R. R. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.265.3.e380 · Cited by 1,747
Balance of carbohydrate and lipid utilization during exercise: the "crossover" concept
Brooks, G. A., & Mercier, J. (1994) · Journal of Applied Physiology · doi:10.1152/jappl.1994.76.6.2253 · Cited by 862
Physiology and Pathophysiology of the Human Sympathoadrenal Neuroendocrine System
Bleich, H. L., Moore, M. J., & Cryer, P. E. (1980) · New England Journal of Medicine · doi:10.1056/nejm198008213030806 · Cited by 652
Self-citationHypokalemia from Beta 2 -Receptor Stimulation by Circulating Epinephrine
Brown, M. J., Brown, D. C., & Murphy, M. B. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312083092303 · Cited by 644
Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis
James, J. H., Luchette, F. A., McCarter, F. D., & Fischer, J. E. (1999) · The Lancet · doi:10.1016/s0140-6736(98)91132-1 · Cited by 538
Levy, B., Gibot, S., Franck, P., Cravoisy, A., & Bollaert, P.-E. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71045-x · Cited by 506
Tolerance to the humoral and hemodynamic effects of caffeine in man.
Robertson, D., Wade, D., Workman, R., Woosley, R. L., & Oates, J. A. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110124 · Cited by 501
Effect of Malnutrition After Acute Stroke on Clinical Outcome
Dávalos, A., Ricart, W., Gonzalez-Huix, F., Soler, S., Marrugat, J., Molins, A., Suñer, R., & Genís, D. (1996) · Stroke · doi:10.1161/01.str.27.6.1028 · Cited by 494
Lactate metabolism: historical context, prior misinterpretations, and current understanding
Ferguson, B. S., Rogatzki, M. J., Goodwin, M. L., Kane, D. A., Rightmire, Z., & Gladden, L. B. (2018) · European Journal of Applied Physiology · doi:10.1007/s00421-017-3795-6 · Cited by 441
“…beyond the scope of this review, this persistent [La − ] elevation may be due to the underlying stress response of trauma or critical care, as catecholamines stimulate ß-adrenergic receptors on skeletal muscle, liberating skeletal muscle glycogen as La − (Clutter et al. 1980; Stainsby et al. 1987).”
BackgroundSurwit, R. S., Schneider, M. S., & Feinglos, M. N. (1992) · Diabetes Care · doi:10.2337/diacare.15.10.1413 · Cited by 400
“Circulating EPI can stimulate glycogenolysis (7), whereas vagal stimulation can inhibit hepatic glucose production (10).”
BackgroundWhite, N. H., Skor, D. A., Cryer, P. E., Levandoski, L. A., Bier, D. M., & Santiago, J. V. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303033080903 · Cited by 391
Self-citationBrain–heart interactions: physiology and clinical implications
Silvani, A., Calandra-Buonaura, G., Dampney, R. A. L., & Cortelli, P. (2016) · Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences · doi:10.1098/rsta.2015.0181 · Cited by 302
“The sympathetic nervous system also controls the heart by promoting adrenal medullary release of adrenaline (epinephrine), whose plasma threshold for decreasing HP is in the range of plasma levels attained during active standing [14].”
BackgroundThe effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects
Chen, X., Iqbal, N., & Boden, G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5479 · Cited by 291
“Epinephrine rose, but the increase was too small to have biologic effects (29).”
BackgroundGlucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus
Epstein, F. H., Cryer, P. E., & Gerich, J. E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507253130405 · Cited by 273
Self-citationRespiratory gas-exchange ratios during graded exercise in fed and fasted trained and untrained men
Bergman, B. C., & Brooks, G. A. (1999) · Journal of Applied Physiology · doi:10.1152/jappl.1999.86.2.479 · Cited by 262
“Greater relative exercise intensities are likely associated with enhanced CHO oxidation, regardless of nutritional state, because of increased recruitment of type II CHO-dependent fibers and increased arterial catecholamine concentration (6), which appear to override any effect of fasting on enhancing lipid oxidation,…”
BackgroundAdrenergic Function in Patients With Panic Anxiety
Nesse, R. M. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790190045005 · Cited by 260
HORMONAL CONTROL OF METABOLISM IN TRAUMA AND SEPSIS
Frayn, K. N. (1986) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1986.tb03288.x · Cited by 243
Day, N. P., Phu, N. H., Bethell, D. P., Mai, N. T., Chau, T. T., Hien, T. T., & White, N. J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)09096-4 · Cited by 230
Pharmacologic and Therapeutic Applications of alpha2-Adrenoceptor Subtypes
Ruffolo, R. R., Nichols, A. J., Stadel, J. M., & Hieble, J. P. (1993) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.33.040193.001331 · Cited by 226
Reece, E. A., Hagay, Z., Roberts, A. B., DeGennaro, N., Homko, C. J., Connolly-Diamond, M., Sherwin, R., Tamborlane, W. V., & Diamond, M. P. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90105-1 · Cited by 220
Campbell, P. J., Bolli, G. B., Cryer, P. E., & Gerich, J. E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198506063122302 · Cited by 218
Self-citationInsulin resistance after abdominal surgery
Thorell, A., Efendic, S., Gutniak, M., Häggmark, T., & Ljungqvist, O. (1994) · Journal of British Surgery · doi:10.1002/bjs.1800810120 · Cited by 206
Myers, J., & Ashley, E. (1997) · Chest · doi:10.1378/chest.111.3.787 · Cited by 200
Adrenomedullary response to maximal stress in humans
Wortsman, J., Frank, S., & Cryer, P. E. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90512-6 · Cited by 201
Self-citationEthanol causes acute inhibition of carbohydrate, fat, and protein oxidation and insulin resistance.
Shelmet, J. J., Reichard, G. A., Skutches, C. L., Hoeldtke, R. D., Owen, O. E., & Boden, G. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113428 · Cited by 199
Use of inotropes and vasopressor agents in critically ill patients
Bangash, M. N., Kong, M., & Pearse, R. M. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01588.x · Cited by 197
“…occur most frequently with adrenergic agonists and PDE inhibitors (PDEIs), which may increase total body oxygen consumption, peripheral insulin resistance, suppression of insulin secretion, increased fatty acid and lactate production and hyperglycaemia (Clutter et al., 1980; Galster et al., 1981).”
BackgroundInfluentialThe Origins of Cachexia in Acute and Chronic Inflammatory Diseases*
Delano, M. J., & Moldawer, L. L. (2006) · Nutrition in Clinical Practice · doi:10.1177/011542650602100168 · Cited by 197
Papakonstantinou, E., Oikonomou, C., Nychas, G., & Dimitriadis, G. D. (2022) · Nutrients · doi:10.3390/nu14040823 · Cited by 199
Catecholamines Regulate the Activity, Secretion, and Synthesis of Renalase
Li, G., Xu, J., Wang, P., Velazquez, H., Li, Y., Wu, Y., & Desir, G. V. (2008) · Circulation · doi:10.1161/circulationaha.107.732032 · Cited by 194
ENDOCRINE AND METABOLIC CHANGES DURING SURGERY: ANAESTHETIC IMPLICATIONS
TRAYNOR, C., & HALL, G. M. (1981) · British Journal of Anaesthesia · doi:10.1093/bja/53.2.153 · Cited by 184
“Cryer and colleagues (Silverberg et al., 1978; Clutter et al., 1980) have attempted to define the circulating concentrations of catecholamines required to produce metabolic and haemodynamic effects by infusing varying concentrations of these agents into normal subjects.”
BackgroundPhysical activity as a metabolic stressor
Coyle, E. F. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.2.512s · Cited by 174
“Hypoglycemia markedly stimulates epinephrine release, probably in an attempt to attenuate reductions in blood glucose concentration by increasing liver glucose output and/or reducing glucose uptake (56, 57).”
BackgroundEffect of physiologic and pharmacologic adrenergic stimulation on heart rate variability
Ahmed, M. W., Kadish, A. H., Parker, M. A., & Goldberger, J. J. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90874-5 · Cited by 174
Bro-Jeppesen, J., Annborn, M., Hassager, C., Wise, M. P., Pelosi, P., Nielsen, N., Erlinge, D., Wanscher, M., Friberg, H., & Kjaergaard, J. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000000691 · Cited by 169
Effects of autonomic stimulation and blockade on signal-averaged P wave duration
Cheema, A. N., Ahmed, M. W., Kadish, A. H., & Goldberger, J. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)80028-f · Cited by 168
“The dose was gradually increased in all subjects to 50 ng/kg body weight per rain and maintained at this infusion rate for 10 rain to achieve steady state (5,6).”
BackgroundSANTIAGO, J. V., CLARKE, W. L., SHAH, S. D., & CRYER, P. E. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-4-877 · Cited by 166
Self-citationGalster, A. D., Clutter, W. E., Cryer, P. E., Collins, J. A., & Bier, D. M. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110211 · Cited by 167
Self-citationReduced Epinephrine Secretion and Hypoglycemia Unawareness in Diabetic Autonomic Neuropathy
HOELDTKE, R. D., BODEN, G., SHUMAN, C. R., & OWEN, O. E. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-4-459 · Cited by 158
Diabetes as a marker of pheochromocytoma in hypertensive patients
Batide-Alanore, A. L., Châtellier, G., & Plouin, P. (2003) · Journal of Hypertension · doi:10.1097/00004872-200309000-00020 · Cited by 157
Hypoglycemia-associated autonomic failure in diabetes
Cryer, P. E. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1115 · Cited by 152
Vestal, R. E., Eiriksson, C. E., Musser, B., Ozaki, L., & Halter, J. B. (1983) · Circulation · doi:10.1161/01.cir.67.1.162 · Cited by 161
Biphasic Adrenergic Modulation of β-Adrenergic Receptors in Man
Tohmeh, J. F., & Cryer, P. E. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109735 · Cited by 113
Self-citationPsychological Stress and Metabolic Control in Patients with Type I Diabetes Mellitus
Kemmer, F. W., Bisping, R., Steingrüber, H.-J., Baar, H., Hardtmann, F., Schlaghecke, R., & Berger, M. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604243141704 · Cited by 146
Tolas, A. G., Pflug, A. E., & Halter, J. B. (1982) · The Journal of the American Dental Association · doi:10.14219/jada.archive.1982.0114 · Cited by 147
Both Inflammatory and Endocrine Mediators Stimulate Host Responses to Sepsis
Watters, J. M., Bessey, P. Q., Dinarello, C. A., Wolff, S. M., & Wilmore, D. W. (1986) · Archives of Surgery · doi:10.1001/archsurg.1986.01400020065008 · Cited by 146
Use of catecholamines in pediatrics
ZARITSKY, A. L., & Chernow, B. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80003-7 · Cited by 142
Hormonal control of substrate cycling in humans.
Miyoshi, H., Shulman, G. I., Peters, E. J., Wolfe, M. H., Elahi, D., & Wolfe, R. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113487 · Cited by 139
Epinephrine and the genesis of hypertension.
Floras, J. S. (1992) · Hypertension · doi:10.1161/01.hyp.19.1.1 · Cited by 154
Acute noradrenergic activation induces insulin resistance in human skeletal muscle
Lembo, G., Capaldo, B., Rendina, V., Iaccarino, G., Napoli, R., Guida, R., Trimarco, B., & Sacca, L. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.2.e242 · Cited by 136
Regulation of Lipolysis in Severely Burned Children
Wolfe, R. R., Herndon, D. N., Peters, E. J., Jahoor, F., Desai, M. H., & Holland, O. B. (1987) · Annals of Surgery · doi:10.1097/00000658-198708000-00016 · Cited by 140
Widom, B., & Simonson, D. C. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-12-904 · Cited by 130
Contraindications to vasoconstrictors in dentistry: Part I
Pe´russe, R., Goulet, J., & Turcotte, J.-Y. (1992) · Oral Surgery Oral Medicine Oral Pathology · doi:10.1016/0030-4220(92)90365-w · Cited by 131
Hägnevik, K., Faxelius, G., Irestedt, L., Lagercrantz, H., Lundell, B. P. W., & Persson, B. (1984) · Acta Paediatrica · doi:10.1111/j.1651-2227.1984.tb09982.x · Cited by 128
Physiologic Consequences of Status Epilepticus
Simon, R. P. (1985) · Epilepsia · doi:10.1111/j.1528-1157.1985.tb05725.x · Cited by 128
Klein, S., Young, V. R., Blackburn, G. L., Bistrian, B. R., & Wolfe, R. R. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112682 · Cited by 123
Hypokalemia from beta2-receptor stimulation by circulating epinephrine
Brown, M. J. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)91107-5 · Cited by 122
Ruffolo, R. R., Jr., & Hieble, J. P. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90058-2 · Cited by 154
Exercise and Glycemic Control in Diabetes: Benefits, Challenges, and Adjustments to Pharmacotherapy
Gulve, E. A. (2008) · Physical Therapy · doi:10.2522/ptj.20080114 · Cited by 120
Islet function and stress hyperglycemia: plasma glucose and epinephrine interaction
Halter, J. B., Beard, J. C., & Porte, D. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.247.1.e47 · Cited by 118
Boden, G. H., Reichard, G., Hoeldtke, R. D., Rezvani, I., & Owen, O. E. (1981) · New England Journal of Medicine · doi:10.1056/nejm198111123052007 · Cited by 121
Distribution and function of peripheral α-adrenoceptors in the cardiovascular system
Ruffolo, R. R., Jr. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90535-0 · Cited by 117
Release and Clearance Rates of Epinephrine in Man: Importance of Arterial Measurements*
Best, J. D., & Halter, J. B. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-2-263 · Cited by 115
Cryer, P. E., Rizza, R. A., Haymond, M. W., & Gerich, J. E. (1980) · Metabolism · doi:10.1016/0026-0495(80)90019-0 · Cited by 115
Self-citationMj, B., Allison, D. J., Jenner, D. A., Lewis, P. J., & Dollery, C. T. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90058-1 · Cited by 115
Effects of Statins on Skeletal Muscle: A Perspective for Physical Therapists
Stasi, S. L. D., MacLeod, T. D., Winters, J. D., & Binder‐Macleod, S. A. (2010) · Physical Therapy · doi:10.2522/ptj.20090251 · Cited by 133
IS ADRENALINE THE CAUSE OF ESSENTIAL HYPERTENSION?
Mj, B., & Macquin, I. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91279-4 · Cited by 123
Slow component of O2 uptake during heavy exercise: adaptation to endurance training
Womack, C. J., Davis, S. E., Blumer, J. L., Barrett, E. J., WELTMAN, A. L., & Gaesser, G. A. (1995) · Journal of Applied Physiology · doi:10.1152/jappl.1995.79.3.838 · Cited by 135
Simões, H. G., Campbell, C. S. G., Kokubun, E., Denadai, B. S., & Baldissera, V. (1999) · European Journal of Applied Physiology and Occupational Physiology · doi:10.1007/s004210050555 · Cited by 108
“Some studies have suggested that there is a threshold intensity for high adrenergic activation (Clutter et al. 1980) and that adrenaline stimulates both glycogenolysis and lactate production during exercise (Exton 1979; Stainsby et al.”
Detection of intravascular injection of regional anaesthetics in children
Fisher, Q. A., Shaffner, D. H., & Yaster, M. (1997) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03015441 · Cited by 105
Thermogenic response to epinephrine in the forearm and abdominal subcutaneous adipose tissue
Simonsen, L., Bülow, J., Madsen, J., & Christensen, N. J. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.263.5.e850 · Cited by 103
Gender-Related Differences in the Metabolic Response to Fasting
Soeters, M. R., Sauerwein, H. P., Groener, J. E. M., Aerts, J. M. F. G., Ackermans, M. T., Glatz, J. F. C., Fliers, E., & Serlie, M. J. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0552 · Cited by 115
Ito, Y., Fuimoto, Y., & Obara, T. (1992) · World Journal of Surgery · doi:10.1007/bf02067379 · Cited by 103
Dopamine pharmacokinetics in critically ill newborn infants
Padbury, J. F., Agata, Y., Baylen, B. G., et al. (1987) · The Journal of Pediatrics · doi:10.1016/s0022-3476(87)80176-2 · Cited by 103
Insulin and glucagon in prevention of hypoglycemia during exercise in humans
Hirsch, I. B., Marker, J. C., Smith, L. J., Spina, R. J., Parvin, C. A., Holloszy, J. O., & Cryer, P. E. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.5.e695 · Cited by 121
Self-citationMüllner, M., Sterz, F. R., Domanovits, H., Behringer, W., Binder, M., & Laggner, A. N. (1997) · Intensive Care Medicine · doi:10.1007/s001340050470 · Cited by 101
“Epinephrine is also known to enhance glycolysis and, thus, lactate production even in absence of tissue hypoxia [17].”
BackgroundRobert, J., Bier, D. M., Zhao, X. H., Matthews, D. E., & Young, V. R. (1982) · Metabolism · doi:10.1016/0026-0495(82)90006-3 · Cited by 98
Self-citationExercise and the Regulation of Adipose Tissue Metabolism
Tsiloulis, T., & Watt, M. J. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.06.016 · Cited by 113
Hypoxia Is Not the Sole Cause of Lactate Production during Shock
Luchette, F. A., Jenkins, W. A., Friend, L. A., Su, C., Fischer, J. E., & James, J. H. (2002) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-200203000-00001 · Cited by 93
Chernow, B. (1983) · Archives of Internal Medicine · doi:10.1001/archinte.143.11.2141 · Cited by 93
Body, J., Cryer, P. E., Offord, K. P., & Heath, H. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110802 · Cited by 94
“(2) at the same nominal infusion rates.”
BackgroundMethodInfluentialSelf-citationBehavioral and physiological effects of ethanol in high-risk and control children: a pilot study
Behar, D., Berg, C. J., Rapoport, J. L., Nelson, W., Linnoila, M., Cohen, M., Bozevich, C., & Marshall, T. (1983) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1983.tb05495.x · Cited by 87
Corssmit, E. P. M., Romijn, J. A., & Sauerwein, H. P. (2001) · Metabolism · doi:10.1053/meta.2001.24195 · Cited by 111
Nocturnal Blood Glucose Control in Type I Diabetes Mellitus
Bolli, G. B., Perriello, G., Fanelli, C. G., & Feo, P. D. (1993) · Diabetes Care · doi:10.2337/diacare.16.3.71 · Cited by 98
“3) (51), plasma glucagon does not change overnight, whereas plasma catecholamines at dawn do not reach a threshold concentration necessary to exert appreciable metabolic effects (71).”
BackgroundElevated plasma catecholamines in hypertensives with primary glomerular diseases.
Ishii, M., Ikeda, T., Takagi, M., Sugimoto, T., Atarashi, K., Igari, T., Uehara, Y., Matsuoka, H., Hirata, Y., Kimura, K., et al. (1983) · Hypertension · doi:10.1161/01.hyp.5.4.545 · Cited by 85
“Unlike PNE, subtle changes in PE lead to some cardiovascular manifestations.(25) The significant correlation observed between PE and pulse pressure supports the accuracy of our measurement of PE.”
Role of epinephrine in acute stress
Wortsman, J. (2002) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(01)00024-x · Cited by 94
“Epinephrine metabolic actions are also expressed fully at the same concentration range as the hemodynamic effects and include increments in blood glycerol, free fatty acids, plasma glucose, blood lactate, b-hydroxybutyrate, and decrements in plasma insulin [11,33].”
BackgroundStable Isotope Methods for Nutritional Investigation
Matthews, D. E., & Bier, D. M. (1983) · Annual Review of Nutrition · doi:10.1146/annurev.nu.03.070183.001521 · Cited by 90
Self-citationEpinephrine in cardiac arrest: A critical review
Paradis, N. A., & Koscove, E. M. (1990) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(05)82289-9 · Cited by 85
Halter, J. B., & Pflug, A. E. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-5-1093 · Cited by 88
Contraindications to vasoconstrictors in dentistry: Part II
Pe´russe, R., Goulet, J., & Turcotte, J.-Y. (1992) · Oral Surgery Oral Medicine Oral Pathology · doi:10.1016/0030-4220(92)90366-x · Cited by 84
Age Differences in the Plasma Clearance Mechanisms for Epinephrine and Norepinephrine in Humans*
Morrow, L., Linares, Ó., Hill, T. J., SANFIELD, J. A., Supiano, M. A., ROSEN, S. G., & Halter, J. B. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-3-508 · Cited by 91
Berk, M. A., Clutter, W. E., Skor, D. A., SHAH, S. D., Gingerich, R. L., Parvin, C. A., & Cryer, P. E. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111898 · Cited by 81
Self-citationStrategies for Reducing Fatal Complications in Liposuction
Cárdenas-Camarena, L., Gerardo, L.-P. A., Durán, H., & Bayter-Marín, J. E. (2017) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000001539 · Cited by 92
Comparison of the direct and indirect effects of epinephrine on hepatic glucose production.
Chu, C. A., Sindelar, D. K., Neal, D. W., Allen, E. J., Donahue, E. P., & Cherrington, A. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119232 · Cited by 81
“(3) suggested that increases in circulating epinephrine can stimulate gluconeogenesis in the human by mobilizing alanine and lactate from muscle and glycerol from adipose tissue.”
BackgroundIntervention with epinephrine in hypotension associated with mastocytosis
TURK, J. W., Oates, J. A., & Roberts, L. J. (1983) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(83)90098-2 · Cited by 81
Regulation of glucose metabolism by sympathochromaffin catecholamines
Clutter, W. E., Rizza, R. A., Gerich, J. E., & Cryer, P. E. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040104 · Cited by 83
Self-citationRole of hepatic autoregulation in defense against hypoglycemia in humans.
Bolli, G. B., Feo, P. D., Perriello, G., Cosmo, S. D., Ventura, M. M., Campbell, P., Brunetti, P., & Gerich, J. E. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111869 · Cited by 80
“5 mg/ml), were infused at rates estimated (25, 26) to raise the circulating concentrations of these catecholamines above those levels observed in the preceding experiments.”
MethodEffect of short- and long-term beta-adrenergic blockade on lipolysis during fasting in humans
Klein, S., Peters, E. J., Holland, O. B., & Wolfe, R. R. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.257.1.e65 · Cited by 76
Lager, I., Attvall, S., Eriksson, B. M., Schenk, H., & Smith, U. (1986) · Diabetologia · doi:10.1007/bf00506530 · Cited by 90
“ability of these hormones to impair insulin release [1, 2]”
BackgroundLactate and acid base as a hemodynamic monitor and markers of cellular perfusion
Allen, M. L. (2011) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3182211aed · Cited by 78
“Inhibition of mitochondrial respiration Anaerobic Hypoxia—systemic (66), regional (67), or microcirculatory Lactate is produced from pyruvate by cells functioning in reduced oxygen conditions provided cells are supplied with sufficient glucose Inhibition of mitochondrial respiration Aerobic Impaired activity of pyruva…”
Gender influences counterregulatory hormone responses to hypoglycemia
Diamond, M. P., Jones, T. W., Caprio, S., Hallarman, L., Connolly-Diamond, M., Addabbo, M., Tamborlane, W. V., & Sherwin, R. S. (1993) · Metabolism · doi:10.1016/0026-0495(93)90152-e · Cited by 77
Epinephrine sensitivity with respect to metabolic rate and other variables in women
Sjöström, L., Schutz, Y., Gudinchet, F., Hegnell, L., Pittet, P., & Jéquier, E. (1983) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1983.245.5.e431 · Cited by 78
Metadata
- Authors
- Clutter, W. E., Bier, D. M., Shah, S. D., & Cryer, P. E.
- Affiliations
- Washington University in St. Louis (US)
- ORCID
- Bier, D M
- Venue
- Journal of Clinical Investigation
- Published
- 1980-07-01
- Volume
- 66
- Issue
- 1
- Pages
- 94-101
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC371510
- OpenAlex
- W2133884882
- Cited by
- 576
- References
- 31
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 4 · 2020: 7 · 2019: 3 · 2018: 9 · 2017: 3 · 2016: 3 · 2015: 9 · 2014: 5 · 2013: 5 · 2012: 5
- FWCI
- 29.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- epinephrine, norepinephrine, heart rate, blood pressure, blood glucose, blood lactate, beta-hydroxybutyrate, insulin, hemodynamic effects, metabolic effects, dose-response relationship
- MeSH terms
- Adult, Blood Glucose, Blood Pressure, Dose-Response Relationship, Drug, Epinephrine, Female, Glucagon, Heart Rate, Humans, Insulin, Kinetics, Male, Metabolic Clearance Rate, Norepinephrine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.